Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
STAT3 Activates miR-155 in Th17 cells and Acts in Concert to Promote Experimental Autoimmune Uveitis.
Autoimmune neurological disorders associated with group-A beta-hemolytic streptococcal infection.
Multiple sclerosis: the role of cytokines in pathogenesis and in therapies.
Epigenetic mechanisms in multiple sclerosis: implications for pathogenesis and treatment.
Natalizumab Treatment Reduces Fatigue in Multiple Sclerosis. Results from the TYNERGY Trial; A Study in the Real Life Setting.
Nitric oxide inhibits CXCL12 expression in neuroinflammation.
Multiple Sclerosis from Bench to Bedside.
Can supplementation with vitamin D reduce the risk or modify the course of autoimmune diseases? A systematic review of the literature.
[A different approach to the care of patients with MS].
Risk factors for idiopathic optic neuritis recurrence.
Psychiatric disorders revealing multiple sclerosis after 20 years of evolvement.
Evaluation of the tolerability and efficacy of Sativex in multiple sclerosis.
Demyelinating disease: Is TOPIC the last trial for clinically isolated syndrome?
Reply to Article: High inbreeding in the Faroe Islands does not appear to constitute a risk factor for multiple sclerosis.
General Practitioner Preferences in Managing Care of Multiple Sclerosis Patients.
Interferon beta-related nephropathy and interstitial lung disease: a new association and a long-term warning.
Microglia activation in multiple sclerosis black holes predicts outcome in progressive patients: An in vivo [(11)C](R)-PK11195-PET pilot study.
In vivo MR imaging of intercellular adhesion molecule-1 expression in an animal model of multiple sclerosis.
Ceramide galactosyltransferase expression is regulated positively by Nkx2.2 and negatively by OLIG2.
Autophagy regulates the therapeutic potential of mesenchymal stem cells in experimental autoimmune encephalomyelitis.
Moving to Fingolimod From Natalizumab in Multiple Sclerosis: The ENIGM Is Not Solved.
Multiple sclerosis: Rapid screening for remyelination-promoting drugs using micropillar arrays.
Development of the Cell Population in the Brain White Matter of Young Children.
Cerebral white matter disease in patients with malignancy: pml versus toxic leucoencephalopathy due to chemotherapy.
Microtubule-stabilizing agents delay the onset of EAE through inhibition of migration.
Pages
« first
‹ previous
…
296
297
298
299
300
301
302
303
304
…
next ›
last »